These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 384741)

  • 1. Uncommon case of type II glycogenosis.
    de Barsy T; Ferrière G; Fernandez-Alvarez E
    Acta Neuropathol; 1979 Aug; 47(3):245-7. PubMed ID: 384741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid maltase deficiency (type II glycogenosis). Morphological and biochemical study of a childhood phenotype.
    Martin JJ; De Barsy T; De Schrijver ; Leroy JG; Palladini G
    J Neurol Sci; 1976 Nov; 30(1):155-66. PubMed ID: 1068222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia.
    Ullrich K; Gröbe H; Korinthenberg R; von Bassewitz DB
    Pathol Res Pract; 1986 Oct; 181(5):627-32. PubMed ID: 2947052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile acid maltase deficiency. II. Muscle fiber hypertrophy and the ultrastructure of end-stage fibers.
    Griffin JL
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 45(1):37-50. PubMed ID: 6199886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of age on biochemical and morphological changes in the semitendinosus muscle of cattle with generalized glycogenosis type II.
    Howell JM; Dorling PR; Cook RD
    Neuropathol Appl Neurobiol; 1984; 10(4):255-66. PubMed ID: 6435005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid maltase deficiency in adults. Clinical, morphological and biochemical study of three patients.
    Bertagnolio B; Di Donato S; Peluchetti D; Rimoldi M; Storchi G; Cornelio F
    Eur Neurol; 1978; 17(4):193-204. PubMed ID: 357152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine glycogenosis type II. Biochemical and morphological characteristics of skeletal muscle in culture.
    Di Marco PN; Howell JM; Dorling PR
    Neuropathol Appl Neurobiol; 1984; 10(5):379-95. PubMed ID: 6395034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The symptomatology, morphology and biochemistry of glycogenosis type II (Pompe) in the adult.
    Schlenska GK; Heene R; Spalke G; Seiler D
    J Neurol; 1976 Jun; 212(3):237-52. PubMed ID: 58976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vacuolated lymphocytes in type II glycogenosis--a diagnostic approach?
    von Bassewitz DB; Bremer HJ; Bourgeois M; Gröbe H; Stoermer J
    Eur J Pediatr; 1977 Dec; 127(1):1-7. PubMed ID: 272287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An especially mild myopathic form of glycogenosis type II. Problems of clinical and light microscopic diagnosis.
    Pongratz D; Schlossmacher I; Koppenwallner C; Hübner G
    Pathol Eur; 1976; 11(1):39-44. PubMed ID: 132627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-1986. A 29-year-old woman with slowly progressive proximal-muscle weakness.
    N Engl J Med; 1986 Sep; 315(11):694-701. PubMed ID: 3092049
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid storage myopathy in infantile Pompe's disease.
    Sarnat HB; Roth SI; Carroll JE; Brown BI; Dungan WT
    Arch Neurol; 1982 Mar; 39(3):180-3. PubMed ID: 6461316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen storage disease in skeletal muscle. Morphological, ultrastructural and biochemical aspects in 10 cases.
    Cabello A; Benlloch T; Franch O; Feliú JF; Ricoy JR
    Acta Neuropathol Suppl; 1981; 7():297-300. PubMed ID: 6939256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "muscular variant" of Pompe disease: clinical, biochemical and histologic characteristics.
    Temple JK; Dunn DW; Blitzer MG; Shapira E
    Am J Med Genet; 1985 Jul; 21(3):597-604. PubMed ID: 3895931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic characteristics of the placenta in glycogen storage disease type II (alpha-1,4-glucosidase deficiency).
    Bendon RW; Hug G
    Am J Obstet Gynecol; 1985 Aug; 152(8):1021-6. PubMed ID: 2411138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vacuolar myopathy with type 2 A fiber atrophy and type 2 B fiber deficiency. A case of childhood form acid alpha-1,4-glucosidase deficiency.
    Matsuishi T; Terasawa K; Yoshida I; Yano E; Yamashita F; Hidaka T; Ishihara O; Yoshino M; Nonaka I; Kurokawa T; Nakamura Y
    Neuropediatrics; 1982 Nov; 13(4):173-6. PubMed ID: 6818487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of heterozygotes for glycogenosis 2 (acid maltase deficiency).
    Loonen MC; Schram AW; Koster JF; Niermeijer MF; Busch HF; Martin JJ; Brouwer-Kelder B; Mekes W; Slee RG; Tager JM
    Clin Genet; 1981 Jan; 19(1):55-63. PubMed ID: 7006871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathology of type II skeletal muscle glycogenosis. A light and electron-microscopic study.
    Hudgson P; Fulthorpe JJ
    J Pathol; 1975 Jul; 116(3):139-47. PubMed ID: 172619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mitigated adult forms of acid maltase deficiency (Pompe's disease). Morphologic and pathobiochemical studies].
    Pongratz D; Hübner G; Deufel T; Wieland OH
    Klin Wochenschr; 1983 Aug; 61(15):743-50. PubMed ID: 6413751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acid maltase deficiency myopathy infantile and adult forms (author's transl)].
    Saenz Lope E; Cocero Oviedo E; Ricoy Campo JR; Benlloch T
    Arch Neurobiol (Madr); 1981; 44(1):49-62. PubMed ID: 6784694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.